XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 30, 2022
Oct. 31, 2021
Cash flows from operating activities:    
Net income $ 112,387 $ 90,854
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 22,321 22,686
Amortization of right-of-use assets 3,475 3,289
Investment impairments and credit loss reserves, net (376) 930
Accretion of deferred financing costs and debt discount 520 361
Deferred income taxes 2,383 (1,540)
Share-based compensation 27,228 40,697
Gain on disposition of business operations and assets (18,256) (34)
Equity in net gains of equity method investments (271) (2,115)
Corporate-owned life insurance, net 23 4,720
Changes in assets and liabilities:    
Accounts receivable, net (9,032) (3,880)
Inventories (3,470) (17,665)
Other assets 4,170 8,130
Accounts payable (3,430) (3,325)
Accrued liabilities 12,127 15,816
Other liabilities (4,289) (6,787)
Net cash provided by operating activities 145,510 152,137
Cash flows from investing activities:    
Proceeds from sales of property, plant and equipment 33 82
Purchase of property, plant and equipment (22,643) (18,081)
Proceeds from sale of investments 2,275 0
Purchase of investments (6,748) (5,832)
Proceeds from sale of business, net of cash disposed 26,322 0
Proceeds from corporate-owned life insurance 5,065 0
Premiums paid for corporate-owned life insurance (5,065) (6,000)
Net cash used in investing activities (761) (29,831)
Cash flows from financing activities:    
Proceeds from revolving line of credit 10,000 20,000
Payments of revolving line of credit (33,000) (24,000)
Proceeds from convertible senior notes 319,500 0
Proceeds from sale of warrants 42,909 0
Purchase of convertible note hedge (72,559) 0
Deferred financing costs (10,253) 0
Payment for employee share-based compensation payroll taxes (13,766) (17,885)
Proceeds from exercise of stock options 620 4,287
Repurchase of common stock (50,000) (97,000)
Net cash provided by (used in) financing activities 193,451 (114,598)
Net increase in cash and cash equivalents 338,200 7,708
Cash and cash equivalents at beginning of period 279,601 268,891
Cash and cash equivalents at end of period 617,801 276,599
Supplemental disclosure of cash flow information:    
Interest paid 10,267 3,237
Income taxes paid 8,749 2,989
Non-cash investing and financing activities:    
Accounts payable related to capital expenditures 3,803 2,424
Conversion of notes into equity $ 0 $ 626